Sullivan & Cromwell has appointed its leading M&A partner Richard Pollack as managing partner of its London office replacing Richard Morrissey who has held the role since 2011.
With management experience as the firm’s co-head of PE and former co-head of its general practice group, Pollack specialises in cross-border mergers and acquisitions across a wide range of industries, as well as in public and private offerings of equity and debt securities on behalf of US and non-US issuers.
His clients include Apollo, Barclays Capital, Compass Partners, Eurazeo, Groupe Bruxelles Lambert, Lightyear Capital, MatlinPatterson Partners, Navitas Capital, Olympus Capital, Ontario Teachers, Perry Capital, Reservoir Capital, Rhône Capital, Ripplewood Holdings and Silver Lake Partners.
Pollack replaces Morrissey, the firm’s formerly the head of the M&A group in Europe and former co-head of the firm’s private equity practice.
The firm’s London office posted an impressive 40% revenue rise to £36.8m this year, despite its headcount remaining relatively flat at 77 fee earners from 78 the year prior.
Sullivan & Cromwell recently won a role advising healthcare and agriculture giant Bayer as it placed a bid to acquire agricultural company Monsanto for $62bn, in a deal which would create the world’s biggest agricultural supplier. Allen & Overy (A&O) is advising Bayer on the financing of the transaction, while Wachtell, Lipton, Rosen & Katz will advise Monsanto through the potential acquisition.